@WHO: Fast-tracking the prequalification of dolutegravir as a generic, affordable #HIV drug is 🔑 to save lives. It will provide children with rapid access to an optimal drug that, to date, has only been available for adults & older children/adolescents. https://t.co/0V1D0HnD59

http://twitter.com/WHO
via IFTTT